These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38908615)

  • 1. Lactobacillus rhamnosus GG ameliorates triptolide-induced liver injury through modulation of the bile acid-FXR axis.
    Hu S; Tang B; Lu C; Wang S; Wu L; Lei Y; Tang L; Zhu H; Wang D; Yang S
    Pharmacol Res; 2024 Aug; 206():107275. PubMed ID: 38908615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota protects from triptolide-induced hepatotoxicity: Key role of propionate and its downstream signalling events.
    Huang JF; Zhao Q; Dai MY; Xiao XR; Zhang T; Zhu WF; Li F
    Pharmacol Res; 2020 May; 155():104752. PubMed ID: 32169656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury.
    Ren L; Song Q; Liu Y; Zhang L; Hao Z; Feng W
    Biochem Biophys Res Commun; 2019 Nov; 520(1):67-72. PubMed ID: 31575408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic pretreatment promotes orally-administered triptolide absorption and aggravates hepatotoxicity and intestinal injury in mice.
    Liu YT; Hu YQ; Wang YL; Huang K; Chen GF; Zhou H; Liu CH; Yang T
    J Ethnopharmacol; 2022 Jun; 292():115224. PubMed ID: 35351577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis.
    Qin D; Pan P; Lyu B; Chen W; Gao Y
    Biomed Pharmacother; 2024 Aug; 177():116942. PubMed ID: 38889641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
    Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
    Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity.
    Jin J; Sun X; Zhao Z; Wang W; Qiu Y; Fu X; Huang M; Huang Z
    Phytomedicine; 2015 Sep; 22(10):894-901. PubMed ID: 26321738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of inflammasome activation in Triptolide-induced acute liver toxicity.
    Yuan Z; Hasnat M; Liang P; Yuan Z; Zhang H; Sun L; Zhang L; Jiang Z
    Int Immunopharmacol; 2019 Oct; 75():105754. PubMed ID: 31352325
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Tong L; Zhang X; Hao H; Liu Q; Zhou Z; Liang X; Liu T; Gong P; Zhang L; Zhai Z; Hao Y; Yi H
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice.
    Huang Y; Chen H; Chen J; Wu Q; Zhang W; Li D; Lu Y; Chen Y
    Phytomedicine; 2024 Oct; 133():155919. PubMed ID: 39153277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
    Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation.
    Yuan Z; Zhang H; Hasnat M; Ding J; Chen X; Liang P; Sun L; Zhang L; Jiang Z
    Toxicology; 2019 Feb; 414():45-56. PubMed ID: 30633930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.
    Sheng L; Jena PK; Hu Y; Liu HX; Nagar N; Kalanetra KM; French SW; French SW; Mills DA; Wan YY
    J Pathol; 2017 Dec; 243(4):431-441. PubMed ID: 28892150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice.
    Kim B; Park KY; Ji Y; Park S; Holzapfel W; Hyun CK
    Biochem Biophys Res Commun; 2016 Apr; 473(2):530-6. PubMed ID: 27018382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalpol coordinately regulates phase I and II detoxification enzymes of Triptolide through CAR and NRF2 pathways to reduce Triptolide-induced hepatotoxicity.
    Fu L; Zhou L; Geng S; Li M; Lu W; Lu Y; Feng Z; Zhou X
    Biomed Pharmacother; 2020 Sep; 129():110379. PubMed ID: 32563148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aflatoxin B1 induces liver injury by disturbing gut microbiota-bile acid-FXR axis in mice.
    Liu Y; Li J; Kang W; Liu S; Liu J; Shi M; Wang Y; Liu X; Chen X; Huang K
    Food Chem Toxicol; 2023 Jun; 176():113751. PubMed ID: 37030333
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Wu L; Zhou J; Zhou A; Lei Y; Tang L; Hu S; Wang S; Xiao X; Chen Q; Tu D; Lu C; Lai Y; Li Y; Zhang X; Tang B; Yang S
    Gut Microbes; 2024; 16(1):2390176. PubMed ID: 39205654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitigation of high-fat diet-induced hepatic steatosis by thyme (
    Sheng X; Zhan P; Wang P; He W; Tian H
    Food Funct; 2024 Jul; 15(14):7333-7347. PubMed ID: 38305590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.